Ido Bachelet

Faculty of Life Sciences and the Institute for Nanotechnology & Advanced Materials, Bar Ilan University

Affiliated withBar Ilan University Bar-Ilan University

Research Area

Biography

Ido Bachelet has not added Biography.
If you are Ido Bachelet and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 3	2013
Publication title Cited by 6	2015

Other Publications

Article	Year
2B4 (CD244) is expressed and functional on human eosinophils. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15611233	2005
Co-culture of mast cells with fibroblasts: a tool to study their crosstalk. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 16110165	2006
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood\| PubMed ID: 16254138	2006
The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16339535	2005
Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. The Journal of allergy and clinical immunology\| PubMed ID: 16750992	2006
CD48 is an allergen and IL-3-induced activation molecule on eosinophils. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16785501	2006
Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. The Journal of biological chemistry\| PubMed ID: 16831868	2006
Mast cells: not only in allergy. Immunology and allergy clinics of North America\| PubMed ID: 16931286	2006
Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. The Journal of allergy and clinical immunology\| PubMed ID: 17088133	2006
CD48 is critically involved in allergic eosinophilic airway inflammation. American journal of respiratory and critical care medicine\| PubMed ID: 17290046	2007
Mast cells as effector cells: a co-stimulating question. Trends in immunology\| PubMed ID: 17625970	2007
Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18424727	2008
DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders. Current opinion in investigational drugs (London, England : 2000)\| PubMed ID: 18465659	2008
CD48 as a novel target in asthma therapy. Recent patents on inflammation & allergy drug discovery\| PubMed ID: 19075961	2007
Targeting an antimicrobial effector function in insect immunity as a pest control strategy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19506247	2009
Tryptase as an inflammatory marker in allergic disease and asthma. Expert review of clinical immunology\| PubMed ID: 20477655	2005
A logic-gated nanorobot for targeted transport of molecular payloads. Science (New York, N.Y.)\| PubMed ID: 22344439	2012
Modular glycosphere assays for high-throughput functional characterization of influenza viruses. BMC biotechnology\| PubMed ID: 23587408	2013
High-resolution antibody dynamics of vaccine-induced immune responses. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 24639495	2014
Universal computing by DNA origami robots in a living animal. Nature nanotechnology\| PubMed ID: 24705510	2014
Cooperativity-based modeling of heterotypic DNA nanostructure assembly. Nucleic acids research\| PubMed ID: 26071955	2015
Meshing complex macro-scale objects into self-assembling bricks. Scientific reports\| PubMed ID: 26226488	2015